Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126852881 | 12685288 | 1 | I | 201506 | 20150709 | 20160825 | 20160825 | PER | US-NOVOPROD-456812 | NOVO NORDISK | 69.00 | YR | E | M | Y | 82.54000 | KG | 20160825 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126852881 | 12685288 | 1 | PS | VICTOZA | LIRAGLUTIDE | 1 | Subcutaneous | 1.2 MG, QD | Y | ES6P006 | 22341 | 1.2 | MG | SOLUTION FOR INJECTION | QD | ||||
| 126852881 | 12685288 | 2 | SS | VICTOZA | LIRAGLUTIDE | 1 | Subcutaneous | 1.8 MG, QD | Y | ES6P006 | 22341 | 1.8 | MG | SOLUTION FOR INJECTION | QD | ||||
| 126852881 | 12685288 | 3 | C | LEVEMIR | INSULIN DETEMIR | 1 | Subcutaneous | UNK | UNKNOWN | 0 | SOLUTION FOR INJECTION | ||||||||
| 126852881 | 12685288 | 4 | C | LEVEMIR | INSULIN DETEMIR | 1 | Subcutaneous | 75 MG, QD | UNKNOWN | 0 | 75 | MG | SOLUTION FOR INJECTION | QD | |||||
| 126852881 | 12685288 | 5 | C | METFORMIN HYDROCHLORIDE. | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, BID | UNKNOWN | 0 | 500 | MG | BID | ||||||
| 126852881 | 12685288 | 6 | C | LORAZEPAM. | LORAZEPAM | 1 | Oral | 1 MG, QD AS NEEDED | UNKNOWN | 0 | 1 | MG | QD | ||||||
| 126852881 | 12685288 | 7 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 20 MG, QD | UNKNOWN | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126852881 | 12685288 | 1 | Type 2 diabetes mellitus |
| 126852881 | 12685288 | 3 | Type 2 diabetes mellitus |
| 126852881 | 12685288 | 5 | Type 2 diabetes mellitus |
| 126852881 | 12685288 | 6 | Product used for unknown indication |
| 126852881 | 12685288 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126852881 | 12685288 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126852881 | 12685288 | Diabetes mellitus inadequate control | |
| 126852881 | 12685288 | Eructation | |
| 126852881 | 12685288 | Headache | |
| 126852881 | 12685288 | Pancreatitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126852881 | 12685288 | 1 | 20140703 | 201506 | 0 | |
| 126852881 | 12685288 | 2 | 201506 | 201506 | 0 | |
| 126852881 | 12685288 | 3 | 2014 | 201506 | 0 | |
| 126852881 | 12685288 | 4 | 201506 | 0 |